Scarica l'app Stockscreener
4.50
2.39%
-0.11
Precedente Chiudi:
$4.61
Aprire:
$4.52
Volume 24 ore:
1.89M
Relative Volume:
0.43
Capitalizzazione di mercato:
$732.05M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
112.50
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
-1.32%
1M Prestazione:
-3.02%
6M Prestazione:
+312.84%
1 anno Prestazione:
+123.88%
Intervallo 1D:
$4.35
$4.69
Intervallo di 1 settimana:
$4.22
$4.905
Portata 52W:
$0.5271
$5.78
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Nome
Ironwood Pharmaceuticals Inc
Settore
Telefono
617-621-7722
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
4.50 | 749.95M | 400.57M | 9.21M | 146.36M | 0.04 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-15 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Iniziato | Leerink Partners | Market Perform |
| 2024-08-08 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Iniziato | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Wells Fargo | Overweight |
| 2023-11-09 | Iniziato | Jefferies | Buy |
| 2023-09-28 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-02 | Iniziato | CapitalOne | Overweight |
| 2022-04-22 | Iniziato | Piper Sandler | Overweight |
| 2020-09-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Iniziato | Northland Capital | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Neutral |
| 2019-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Aggiornamento | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Iniziato | H.C. Wainwright | Sell |
| 2018-05-09 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Downgrade | Mizuho | Buy → Neutral |
| 2017-07-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Iniziato | Wells Fargo | Outperform |
| 2017-04-07 | Reiterato | Mizuho | Buy |
| 2017-02-22 | Reiterato | Barclays | Equal Weight |
| 2016-11-04 | Reiterato | Mizuho | Buy |
| 2016-10-24 | Reiterato | Wedbush | Neutral |
| 2016-10-10 | Reiterato | Mizuho | Buy |
| 2016-09-27 | Reiterato | WallachBeth | Hold |
Mostra tutto
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock? - Finviz
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 5.7%Here's What Happened - MarketBeat
3 Stocks Trading Near $5 With Massive Earnings Upside - Investing.com
Aug Intraday: Can CHARR expand into new marketsJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
What Recent Medicare Pricing Terms Mean For The Ironwood Pharmaceuticals (IRWD) Investment Story - Yahoo Finance
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption? - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Lowers Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating - Finviz
Craig-Hallum bullish on Ironwood Pharmaceuticals (IRWD), keeps buy rating - MSN
11 Cheap Hot Stocks to Invest In Right Now - Insider Monkey
Day Trade: What is the PEG ratio of RRBIWeekly Trade Summary & High Win Rate Trade Tips - baoquankhu1.vn
Nasdaq Moves: Is GGNPRB attractive at current valuationGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Ironwood Pharmaceuticals stock soars on strong 2026 guidance By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Fits the Minervini High-Growth Momentum Trend Template - Chartmill
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Can Ironwood Pharmaceuticals Inc. outperform in the next rallyJuly 2025 Price Swings & Detailed Earnings Play Strategies - mfd.ru
Does Ironwood Pharmaceuticals Inc. stock benefit from AI growth2025 Market Trends & Daily Volume Surge Signals - mfd.ru
Aug Gainers: Can Ironwood Pharmaceuticals Inc outperform in the next rally2025 Dividend Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
EPS Watch: Can Ironwood Pharmaceuticals Inc maintain sales growthMarket Volume Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Is Ironwood Pharmaceuticals Inc. stock risky to hold now2025 Analyst Calls & Weekly Top Performers Watchlists - mfd.ru
Zacks.com featured highlights include IPG Photonics, Ironwood and Science Applications - Yahoo Finance
Jobs Data: Can Ironwood Pharmaceuticals Inc maintain sales growthSwing Trade & Capital Efficiency Focused Ideas - baoquankhu1.vn
Zacks Research Issues Optimistic Forecast for IRWD Earnings - MarketBeat
Returns Recap: Can Ironwood Pharmaceuticals Inc. stock double in the next year2025 Earnings Impact & Daily Momentum Trading Reports - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 8.4%Here's Why - MarketBeat
Best Penny Stocks To Watch TodayJanuary 2nd - MarketBeat
Zacks Research Has Positive Outlook for IRWD Q4 Earnings - MarketBeat
Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients - MSN
Weekly Earnings: Is Ironwood Pharmaceuticals Inc forming a breakout patternJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Aug Weekly: Is Ironwood Pharmaceuticals Inc forming a breakout patternPortfolio Profit Report & Verified Technical Trade Signals - baoquankhu1.vn
Promising Pharmaceutical Stocks To ConsiderJanuary 2nd - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 5.4%Here's Why - MarketBeat
Chipmakers Recap: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Insider Sell: Should you avoid Ironwood Pharmaceuticals Inc. stock right nowMarket Sentiment Review & Entry Point Strategy Guides - baoquankhu1.vn
Ironwood Pharmaceuticals (IRWD) Price Target Increased by 94.00% to 4.95 - Nasdaq
Growth Recap: Does Ironwood Pharmaceuticals Inc have declining or rising EPSWeekly Market Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 10.7%Here's What Happened - MarketBeat
Winners Losers: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentJuly 2025 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Published on: 2026-01-10 17:20:03 - Улправда
Ironwood Pharma resolves Ferring dispute, amends license terms - MSN
Ironwood stock rises 27% on upbeat revenue guidance for 2026 - MSN
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating - MarketBeat
5 Small Drug Stocks to Buy as Industry Recovery Picks Up - Yahoo Finance
Ironwood hits 52-week high as AbbVie-partnered Linzess boosts 2026 outlook - MSN
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Craig Hallum - MarketBeat
Why did Ironwood Pharmaceuticals stock skyrocket today? - MSN
There's No Escaping Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Muted Revenues Despite A 32% Share Price Rise - 富途牛牛
Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):